SETDB1 and breast carcinoma: Cardamonin could suppress the expression of multiple stem cell-associated histone modifying genes including SETDB1, and prevent the enrichment of breast cancer stem-like cells when combined with chemotherapeutic drugs (Jia et al., 2016).